Search results
Results from the WOW.Com Content Network
Dengue virus has four confirmed serotypes; infection with one type usually gives lifelong immunity to that type, but only short-term immunity to the others. Subsequent infection with a different type increases the risk of severe complications. [9] The symptoms of dengue resemble many other diseases including malaria, influenza, and Zika. [10]
Dengue virus (DENV) is the cause of dengue fever.It is a mosquito-borne, single positive-stranded RNA virus of the family Flaviviridae; genus Flavivirus. [1] [2] Four serotypes of the virus have been found, and a reported fifth has yet to be confirmed, [3] [4] [5] all of which can cause the full spectrum of disease. [1]
Viral hemorrhagic fevers include dengue hemorrhagic fever and dengue shock syndrome. Leukemia may also cause coagulopathy. Furthermore, cystic fibrosis has been known to cause bleeding diathesis, especially in undiagnosed infants, due to malabsorption of fat soluble vitamins like vitamin K. [citation needed]
Those that do develop symptoms typically recover after about one week, said the Florida Department of Health in Miami-Dade. About 1 out of 20 people who initially get sick with dengue will develop ...
The most common viral disease transmitted by arthropods, [14] dengue has a disease burden estimated to be 1600 disability-adjusted life years per million population, which is similar to tuberculosis, another childhood and tropical diseases. [15] As a tropical disease dengue is deemed only second in importance to malaria, [5] though the World ...
Ultimately, Cori was diagnosed with lupus, an autoimmune disease in which your body's immune system attacks your own tissues and organs, per the Mayo Clinic. In 2024, she had a stroke.
Dengue incidence rates have risen sharply within urban areas which have recently become endemic hot spots for the disease. [57] The recent spread of Dengue can also be attributed to rapid population growth, increased coagulation in urban areas, and global travel. Without sufficient vector control, the dengue virus has evolved rapidly over time ...
In December 2018, Dengvaxia was approved in the European Union. [7]In May 2019, Dengvaxia was approved in the United States as the first vaccine approved for the prevention of dengue disease caused by all dengue virus serotypes (1, 2, 3 and 4) in people ages nine through 16 who have laboratory-confirmed previous dengue infection and who live in endemic areas.